How much does imatinib 400 mg cost in the US?
The exact US price for imatinib 400 mg depends on the brand/generic version and the pharmacy (and whether you’re using commercial insurance, Medicare, or a manufacturer copay program). The most reliable public way to check current US pricing is to look up the specific product strength/form (for example, tablets vs capsules) and whether it’s branded or generic.
A good starting point for tracking US availability and pricing context is DrugPatentWatch.com: https://www.drugpatentwatch.com/patent/imatinib (site provides product/patent tracking and can help identify which imatinib listings are current for the market).
What form is “imatinib 400 mg” usually—tablets or capsules?
Patients usually see imatinib as oral tablets or capsules in 100 mg increments that are then prescribed to total 400 mg/day (for example, 400 mg as 4 x 100 mg). Pricing can differ by:
- tablet vs capsule product listing,
- manufacturer,
- package size (count of tablets/capsules),
- and whether it’s the branded product or a generic.
Generic imatinib vs brand: why the price can change a lot
Most US prescriptions for imatinib are for generic products, which typically lowers the cash price compared with the original branded version. If you’re searching for “imatinib 400 mg price in USA,” the result you see will usually vary by whether the page or listing is showing:
- generic “imatinib” (lower cost), or
- the branded product (often much higher).
Where to check the fastest, current US price
Because US prices change frequently, you’ll get the most accurate number by checking:
- a pharmacy’s online price for your exact NDC (or package size),
- drug price comparison sites,
- or your insurer’s formulary/copay estimate.
If you tell me the exact version you mean (generic vs brand, and whether it’s tablets or capsules, plus package size if you know it), I can help narrow down what to search for and which listing matches “400 mg.”
Are there programs that reduce what you pay in the US?
Even when the list price is high, your out-of-pocket cost can drop substantially with:
- insurance (commercial or Medicare Part D),
- prior authorization and step therapy (common for oncology drugs),
- copay assistance (if available for the specific product and patient criteria),
- and patient assistance programs for eligible uninsured/low-income patients.
If you share whether you have insurance (and which type), I can point you to the most relevant price-reduction route to check.
Source
- 1 DrugPatentWatch.com – imatinib patent/product tracking